A comparative study of low dose magnesium sulphate (Dhaka regime) and Pritchard regime for the management of impending eclampsia and eclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20172043Keywords:
Eclampsia, Low dose magnesium sulphate (Dhaka regime) regime, MgSO4, Pritchard regimeAbstract
Background: Eclampsia is a common obstetrical emergency though preventable, yet remains a leading cause of maternal and perinatal morbidity and mortality in the developing world. Pritchard regime is most widely used magnesium sulphate regime for control of eclamptic fits but its dose related toxicity is a major concern among Indian women with low BMI and at peripheral institutions where the patients monitoring is limited. The objective was to study the efficacy of low dose MgSO4 regime (Dhaka regime) for control of convulsions in eclampsia and prevention of convulsions in impending eclampsia, to assess the magnesium related toxicity and to analyze the maternal and perinatal outcomes as compared to standard Pritchard regime.
Methods: This prospective study was carried out in the Department of obstetrics and Gynaecology at Patna Medical College and Hospital, Patna. Study was done on 80 patients of eclampsia and impending eclampsia. Patients were divided into two groups A and B. Group A (n=40) received low dose MgSO4 regime (Dhaka regime) and Group B (n=40) received standard Pritchard regime. Results were analysed using statistical package of social sciences (SPSS) 21.0. Statistical significance was set at p ≤0.05.
Results: In the present study, convulsions were controlled in 95% of eclampsia cases with low dose magnesium sulphate (Dhaka) regime. Recurrence of convulsion was seen in both groups. None of the patients with impending eclampsia in both the groups developed the seizure during entire treatment period. Signs of impending MgSO4 toxicity and the mean amount of magnesium sulphate received was found more in Pritchard regime group (22.5gms in Group A and 39gms in Group B) and was statistically significant with p value <0.001. There were 3 maternal deaths in present study.
Conclusions: Low dose magnesium sulphate is as effective as standard Pritchard regime in controlling the eclamptic fits and preventing its recurrence with comparable maternal and perinatal outcome and less chances of magnesium toxicity. This regimen may be more suitable for use in Indian women with low BMI and in resource poor settings where clinical monitoring is limited.
References
The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63.
Begum R, Begum A, Johanson R, Ali MN, Akhtar S. A low dose (Dhaka) magnesium sulphate regimen for eclampsia: clinical findings and serum magnesium levels. Acta Obstet Gynecol Scand. 2001;80(11):998-1002.
Mahajan NN, Thomas A, Soni RN, Gaikwad NL, Jain SM. Padhar regime-A low dose magnesium sulphate treatment for eclampsia. Gynecol Obstet Invest. 2008;30:20.
Pritchard JA. The use of magnesium ion in the management of eclamptogenic toxaemia. Surgical Gynecol Obstet. 1955;100(2):131-40.
Sardesai SP, Patil A, Maira S, Patil U. Low dose magnesium sulphate therapy for eclampsia and imminent eclampsia: Regime tailored for Indian women. Int J Gynecol Obstet. 2000;70:B45-6.
Flower CA. Magnesium sulphate in toxaemia of pregnancy-New dosage schedule based on body weight. Obstet Gynecol. 1962;19:315-27.
Mahajan NN, Thomas A, Soni RN, Gaikwad NL, Jain SM. Padhar Regime-a low dose magnesium sulphate treatment for eclampsia. Gynecol Obstet Invest. 2009;67:20-4.
Malapaka SVN, Ballal PK. Low-dose magnesium sulphate versus Pritchard regimen for the treatment of eclampsia imminent eclampsia. Intern J Gynecol Obstet India. 2011;115:70-2.
Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet and Gynecol. 1990;163:460-5.
Devi K. Review of Eclampsia. J Obstet Gynecol India. 1976;26:53-8.
Biswas A, Modak R, Baksi S, Biswas S. Epidemiological study of eclampsia in a referral teaching hospital. 2005;103(6):323-4.
Jana N, Dasgupta S, Das AK, Santra D, Samanta B. Experience of a low dose magnesium sulphate regimen for the management of eclampsia over a decade. Int J Gynecol Obstet. 2013;122(1):13-17.
Bangal V, Kwatra A, Raghav S and Jadhav S. Low dose magnesium sulphate regime for Eclampsia. Pravara Med Rev. 2009;4(3):13-5.
Dorset L. Intramuscular injection of magnesium sulphate for control of convulsion in Eclampsia; Am J Obstet Gynecol. 1926;11:227-31.
Krishna M. The curative treatment of Eclampsia- a critical review. J Obstet Gynecol India. 1958;9:1-15.
Sibai BM, Mc Cubbin JH, Anderson GD, Lipshitz J, Dilsts PV Jr. Eclampsia: Observations from 67 recent cases. Obstet Gynecol. 1981;58(5):609-13.
Sibai BM. Magnesium sulphate is the ideal anticonvulsant in preeclampsia eclampsia. Am J Obstet Gynecol. 1990;162:1141-5.
Begum R, Begum A, Johanson R, Ali MN and Akhtar SA low dose ('Dhaka') magnesium sulphate regime for Eclampsia clinical findings and serum magnesium levels. Acta Obstet Gynecol Scand. 2001;80:998-1002.
Shilva, Saha SC, Kalra J, Prasad R. Safety and efficacy of low dose magnesium sulphate in the treatment of eclampsia. Int J Gynecol Obstet. 2007;97(2):150-1.
Desai P, Badheka H, Barbaiya M. Changes in perinatal outcome due to magnesium sulphate in eclampsia. J Obstet Gynecol India. 1995;45:732-5.
Laxmi M, Neha G. Can we improve maternal and foetal outcome in eclampsia by low dose magnesium sulphate? Asian J Obstet Gynecol Practice. 2011;1:17-20.
